<p>– EDP2939 Phase 2 trial in moderate psoriasis fully enrolled with topline data expected early Q4 2023– Completed $25.5 Million Private Placement– Restructured and reduced secured debt with Ho
Please note this is an concerning the UK Prime Minister Boris Johnson unconfirmed rumour What we do know is: – The Guardian, UK press, report that Johnson's doctors are concerned
Leave a Comment